TITLE

Challenges in Complex Care: Managing Pulmonary Hypertension in Progressive Care

AUTHOR(S)
L., Savage
PUB. DATE
April 2008
SOURCE
Critical Care Nurse;Apr2008, Vol. 28 Issue 2, pe3
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Challenges in Complex Care: Managing Pulmonary Hypertension in Progressive Care," by L. Savage is presented.
ACCESSION #
31609338

 

Related Articles

  • Treating pulmonary hypertension. Lillington, Glen A. // Cortlandt Forum;12/20/95, Vol. 8 Issue 12, p53 

    Answers a question about treatment of pulmonary hypertension. Use of oxygen administration.

  • Sildenafil (Viagra) May Help Improve Control of Pulmonary Hypertension. Ghofrani, H.A.; Wiedemann, R.; Rose, F.; Olschewski, H.; Schermuly, R.T.; Weissmann, N.; Seeger, W.; Grimminger, F. // Annals of Internal Medicine;4/2/2002, Vol. 136 Issue 7, pI35 

    Examines the efficacy of sildenafil in the treatment of pulmonary hypertension. Characterization of pulmonary hypertension; Enhancement on the actions of iloprost and nitric oxide; Combination of sildenafil with standard treatments.

  • Current Management of Primary Pulmonary Hypertension. de Backer, T.L.M.; Smedema, J-P.; Carlier, S.G. // BioDrugs;2001, Vol. 15 Issue 12, p801 

    Primary pulmonary hypertension (PPH) is a rare disorder of the lung vasculature characterised by an increase in pulmonary artery pressure. Although the aetiology of this disease remains unknown, knowledge of the pathophysiology of the disease has advanced considerably. Diagnosis of PPH is...

  • Medical treatment of primary pulmonary hypertension.  // American Family Physician;6/1/1995, Vol. 51 Issue 8, p2002 

    Cites a review by rich on advances in the medical treatment of primary pulmonary hypertension, published in the January 19, 1995 issue of American Journal of Cardiology. Vasodilator therapy; Empiric therapy with calcium antagonists; Recommendation of the use of long-term anticoagulant therapy.

  • Retraction Statement.  // Perfusion;Nov2011, Vol. 26 Issue 6, p546 

    The article ‘Treating pulmonary hypertension post cardiopulmonary bypass in pigs: milrinone vs. sildenafil analog’ by F Urdaneta, EB Lobato, T Beaver, JD Muehlschlegel, DS Kirby, C Klodell and A Sidi published in Perfusion 2008 23: 117-125, 10.1177/0267659108094739 has been retracted.

  • New Hope for Pulmonary Hypertension.  // AARC Times;Dec2014, Vol. 38 Issue 12, p56 

    The article discusses the findings of a study from the University of Calfornia Los Angeles (UCLA) which shows the role of a high density lipoprotein (HDL) peptide in reducing oxidized lipids that are found in pulmonary hypertension.

  • Fund-raiser to benefit Peyton Montgomery.  // Lakelander (Whitney, TX);7/23/2008, Vol. 22 Issue 30, p7 

    The article reports on the benefit fund raiser to help the family of Peyton Montgomery, an infant who was born with pulmonary hypertension in Texas.

  • Tx of severe pulmonary hypertension.  // Modern Medicine;Apr96, Vol. 64 Issue 4, p21 

    Reports on the approval and availability of epoprostenol sodium for injection used for the treatment of severe cases of primary pulmonary hypertension. Flolan as the commercial name of the drug; Manufacturer; Effectiveness.

  • Current Management of Primary Pulmonary Hypertension. Klings, E.S.; Farber, H.W. // Drugs;Oct2001, Vol. 61 Issue 13, p1945 

    Primary pulmonary hypertension (PPH) is a rare disorder with an annual incidence of 1 to 2 per million people. The aetiology of this disorder is unknown, but it appears to result from an abnormal interaction of environmental and genetic factors leading to a vasculopathy. The pulmonary arteries...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics